PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

PRVL was delisted on the 21st of January, 2021.

Back to rankings

38 hedge funds and large institutions have $349M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$182M
2
+$36.2M
3
+$31.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$15.7M
5
BC
Boxer Capital
California
+$14.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$182M
2
$36.2M
3
$31.6M
4
$15.7M
5
$14.8M
6
$10.8M
7
$8.83M
8
$8.67M
9
$8.39M
10
$6.6M
11
$4.07M
12
$3.35M
13
$2.64M
14
$2.38M
15
$1.73M
16
$1.32M
17
$1.19M
18
$1.01M
19
$990K
20
$936K
21
$792K
22
$660K
23
$652K
24
$615K
25
$520K
1
2